Exploring the connection between contraceptive use and ovarian cancer's immune microenvironment, including TILs, TAMs, and therapeutic implications.
Discover how LHRHR-targeting peptides enable precise siRNA delivery to ovarian tumors through intraperitoneal administration, offering new hope for cancer treatment.
Discover how groundbreaking research is identifying genetic loci associated with ovarian cancer outcomes, paving the way for personalized treatments and improved survival predictions.